Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)

The FOCUS-2 trial in children complements the recently announced FOCUS-3 trial in adolescents with ADHDNEW YORK, July 07, 2026 (GLOBE NEWSWIRE) ...

Why losing weight isn't just about counting calories — and what to do about it

When it comes to losing weight, it turns out the simple math of counting calories doesn’t always add up. Counting calories ...